An unusual complication of a common endemic disease: clinical and laboratory aspects of patients with brucella epididymoorchitis in the north of Iran
<p>Abstract</p> <p>Background</p> <p>Brucella epididymoorchitis(BEO) is a focal complication of human brucellosis and has been reported in 2-20% of patients with brucellosis. Brucellosis is an endemic disease in Iran. The incidence of the disease in this country is 34 p...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-08-01
|
| Series: | BMC Research Notes |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1756-0500/4/286 |
| _version_ | 1818493956933025792 |
|---|---|
| author | Tayebi Atefe Davoody Ali R Ghassemian Roya Najafi Narges |
| author_facet | Tayebi Atefe Davoody Ali R Ghassemian Roya Najafi Narges |
| author_sort | Tayebi Atefe |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Brucella epididymoorchitis(BEO) is a focal complication of human brucellosis and has been reported in 2-20% of patients with brucellosis. Brucellosis is an endemic disease in Iran. The incidence of the disease in this country is 34 per 100 000 per year.</p> <p>Methods</p> <p>In a retrospective study, we identified 30 cases of Brucella epididymoorchitis in two teaching hospitals in the north of Iran during 1997-2009.</p> <p>Findings</p> <p>Epididymoorchitis occurred in 11.1% of male patients with brucellosis. The average age was 25.5 ± 12.43 years. Pain and scrotal swelling (100%) and fever (96.7%) were the most common symptoms. Different treatment regimens were administered including doxycycline plus rifampin (60%), doxycycline plus rifampin plus aminoglycoside for the first two weeks (36.6%) and doxycycline plus cotrimoxazole(3.4%). Ten percent of the patients did not respond to antibiotic therapy and required surgical drainage or orchiectomy.</p> <p>Conclusions</p> <p>In brucellosis endemic areas, clinicians who encounter patients with epididymoorchitis should consider the likelihood of brucellosis. A careful history and physical examination and an immediate laboratory evaluation help to make a correct diagnosis. Generally, classical therapy of brucellosis is adequate for the treatment of epididymoorchitis.</p> |
| first_indexed | 2024-12-10T18:00:35Z |
| format | Article |
| id | doaj.art-aacc5d8cf28646e7a453a865cdaf0333 |
| institution | Directory Open Access Journal |
| issn | 1756-0500 |
| language | English |
| last_indexed | 2024-12-10T18:00:35Z |
| publishDate | 2011-08-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Research Notes |
| spelling | doaj.art-aacc5d8cf28646e7a453a865cdaf03332022-12-22T01:38:48ZengBMCBMC Research Notes1756-05002011-08-014128610.1186/1756-0500-4-286An unusual complication of a common endemic disease: clinical and laboratory aspects of patients with brucella epididymoorchitis in the north of IranTayebi AtefeDavoody Ali RGhassemian RoyaNajafi Narges<p>Abstract</p> <p>Background</p> <p>Brucella epididymoorchitis(BEO) is a focal complication of human brucellosis and has been reported in 2-20% of patients with brucellosis. Brucellosis is an endemic disease in Iran. The incidence of the disease in this country is 34 per 100 000 per year.</p> <p>Methods</p> <p>In a retrospective study, we identified 30 cases of Brucella epididymoorchitis in two teaching hospitals in the north of Iran during 1997-2009.</p> <p>Findings</p> <p>Epididymoorchitis occurred in 11.1% of male patients with brucellosis. The average age was 25.5 ± 12.43 years. Pain and scrotal swelling (100%) and fever (96.7%) were the most common symptoms. Different treatment regimens were administered including doxycycline plus rifampin (60%), doxycycline plus rifampin plus aminoglycoside for the first two weeks (36.6%) and doxycycline plus cotrimoxazole(3.4%). Ten percent of the patients did not respond to antibiotic therapy and required surgical drainage or orchiectomy.</p> <p>Conclusions</p> <p>In brucellosis endemic areas, clinicians who encounter patients with epididymoorchitis should consider the likelihood of brucellosis. A careful history and physical examination and an immediate laboratory evaluation help to make a correct diagnosis. Generally, classical therapy of brucellosis is adequate for the treatment of epididymoorchitis.</p>http://www.biomedcentral.com/1756-0500/4/286BrucellosisEpididymoorchitisTesticular abscess |
| spellingShingle | Tayebi Atefe Davoody Ali R Ghassemian Roya Najafi Narges An unusual complication of a common endemic disease: clinical and laboratory aspects of patients with brucella epididymoorchitis in the north of Iran BMC Research Notes Brucellosis Epididymoorchitis Testicular abscess |
| title | An unusual complication of a common endemic disease: clinical and laboratory aspects of patients with brucella epididymoorchitis in the north of Iran |
| title_full | An unusual complication of a common endemic disease: clinical and laboratory aspects of patients with brucella epididymoorchitis in the north of Iran |
| title_fullStr | An unusual complication of a common endemic disease: clinical and laboratory aspects of patients with brucella epididymoorchitis in the north of Iran |
| title_full_unstemmed | An unusual complication of a common endemic disease: clinical and laboratory aspects of patients with brucella epididymoorchitis in the north of Iran |
| title_short | An unusual complication of a common endemic disease: clinical and laboratory aspects of patients with brucella epididymoorchitis in the north of Iran |
| title_sort | unusual complication of a common endemic disease clinical and laboratory aspects of patients with brucella epididymoorchitis in the north of iran |
| topic | Brucellosis Epididymoorchitis Testicular abscess |
| url | http://www.biomedcentral.com/1756-0500/4/286 |
| work_keys_str_mv | AT tayebiatefe anunusualcomplicationofacommonendemicdiseaseclinicalandlaboratoryaspectsofpatientswithbrucellaepididymoorchitisinthenorthofiran AT davoodyalir anunusualcomplicationofacommonendemicdiseaseclinicalandlaboratoryaspectsofpatientswithbrucellaepididymoorchitisinthenorthofiran AT ghassemianroya anunusualcomplicationofacommonendemicdiseaseclinicalandlaboratoryaspectsofpatientswithbrucellaepididymoorchitisinthenorthofiran AT najafinarges anunusualcomplicationofacommonendemicdiseaseclinicalandlaboratoryaspectsofpatientswithbrucellaepididymoorchitisinthenorthofiran AT tayebiatefe unusualcomplicationofacommonendemicdiseaseclinicalandlaboratoryaspectsofpatientswithbrucellaepididymoorchitisinthenorthofiran AT davoodyalir unusualcomplicationofacommonendemicdiseaseclinicalandlaboratoryaspectsofpatientswithbrucellaepididymoorchitisinthenorthofiran AT ghassemianroya unusualcomplicationofacommonendemicdiseaseclinicalandlaboratoryaspectsofpatientswithbrucellaepididymoorchitisinthenorthofiran AT najafinarges unusualcomplicationofacommonendemicdiseaseclinicalandlaboratoryaspectsofpatientswithbrucellaepididymoorchitisinthenorthofiran |